Investor's Business Daily on MSN
Biotech Leader Travere Therapeutics Eyes Buy Point After More Than Doubling
Thursday's IBD 50 Growth Stocks To Watch pick, biotech leader Travere Therapeutics TVTX, is approaching its latest buy point ...
Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands ...
Bloom Energy, Thermo Fisher Scientific, AbbVie, Lumentum, and Qualigen Therapeutics are the five Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are shares ...
TipRanks on MSN
Cathie Wood Loads Up on This Beaten-Down Biotech Stock
Investing in biotech stocks is a risky business. While shares can potentially soar majestically on regulatory approval or ...
As the U.S. market grapples with a mix of earnings reports and renewed U.S.-China trade tensions, major indices like the Nasdaq, Dow Jones Industrial Average, and S&P 500 have recently faced downward ...
Bloom Energy, AbbVie, Thermo Fisher Scientific, Aptevo Therapeutics, Lumentum, Danaher, and NeuroBo Pharmaceuticals are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...
In this article, we will be taking a look at the 15 Best Biotech Penny Stocks to Invest in Right Now. Jared Holz, the healthcare strategist for Mizuho, spoke on CNBC’s “Closing Bell Overtime” in July ...
Urica Therapeutics, a majority-owned subsidiary of Fortress, reported that Crystalys Therapeutics has dosed the first ...
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter: Agios ...
Incyte Corporation (NASDAQ:INCY) rounds out the top three as a biotech growth powerhouse. Trading at $87.30, Incyte offers 19.7% potential upside to fair value while projecting 4,071.7% EPS growth in ...
The handful of analysts following the stock seem to agree that AI-powered drug discovery could give the company an advantage. Among five analysts following the stock, none have a sell rating, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results